Hwa Jung Ryu South Korea
Jeng-Hsien Lin Taiwan
Hours | Speakers | Title |
---|---|---|
14:40 - 14:55 | Leong Kin Fon | Vascular birthmarks , what , why and how ? In the current classification of vascular anomalies , it is classified into two broad biologic categories : vascular tumors and vascular malformations . <br/><br/>Vascular tumors have increased endothelial cell turnover and undergo mitosis. They grow disproportion to the child. Vascular tumors are subdivided on the basis of presence or absence of endothelial cell glucose transporter 1 (GLUT1) isoform protein.<br/>Infantile hemangiomas and angiosarcomas express GLUT1 protein, whereas congenital hemangiomas and kaposiform hemangioendotheliomas do not . <br/><br/>In contrast, malformations are not tumors and thus do not exhibit increased endothelial cell turnover.<br/>They are defined as structural abnormalities that grow in proportion to the child .<br/>Vascular malformations are subdivided into slow-versus fast- flow malformations.<br/>Slow-flow malformations include various combinations of venous, capillary, and lymphatic elements, whereas fast-flow malformations must contain an arterial component . <br/><br/>Vascular tumors<br/>a. Infantile hemangioma<br/>b. Congenital Hemangioma<br/>c. Kaposiform hemangioendothelioma and Tufted angioma <br/>d. Angiosarcoma <br/><br/>Vascular malformations<br/>a. Slow Flow : Capillary , Venous , Lymphatic or combined <br/>b. Fast Flow : Arteriovenous malformation<br/>c. Mixed <br/><br/>This system allows more consistent and accurate diagnoses as well as long term outcome and treatment options<br/>.i.e. Oral Propanolol is only for infantile hemangioma , topical Timolol for superficial hemangioma and Oral Sirolimus is considered for Kaposiform hemangioendothelioma and lymphangioma. It has been widely embraced by clinicians and radiologists who most often deal with vascular anomalies. |
14:55 - 15:10 | Kuo-Liang Cheng | Vascular resurfacing: A new approach of high clearances of vascular plexus for facial erythema, dark circle and sensitive skin Facial telangiectasis has been predominantly and effectively treated with dye lasers for a long time. However, failure to remove chromophore poor small vessels or high pressure vessels and purpura formation at treated areas make vessels clearance at treated areas incomplete, fluctuating and easily recurring. High hemoglobin absorption wavelength of 532 nm with large spot size and delicate pulse duration setting may easily disrupt various size of vessels at different skin levels at one session with designed multilayer approach which is proposed as the term: vascular resurfacing. The concept of vascular resurfacing increases success in removing more telangiectasia with its connecting plexus at single treatment. |
15:10 - 15:25 | Firas Al-Niaimi | My approach to rosacea: From cosmeceuticals, drugs, and energy-based devices Comming Soon |
15:25 - 15:40 | Ivan Perez | Exploring the high potential of a new long-pulsed KTP-532/1064 nm laser for a variety of vascular lesions Background<br/>Vascular lesions present a challenge to the dermatologist because of the large range of anatomical characteristics, especially regarding the deeper-sited vessels. A new long-pulsed KTP (LP-KTP) 532 nm/1064 nm system has been developed which offers macropulses comprising a single pulse (formerly termed continuous wave), sub-micro (300 µs) or sub-milli (1.5 ms) subpulses at both 532 nm and 1064 nm with adjustable cryocooling.<br/>Objective<br/>To demonstrate the enhanced ability offered by this new system to treat a number of vascular lesions existing at a variety of depths, both on and off the face.<br/>Materials and Methods<br/>Treatments are presented with the new LP-KTP 532 system of examples of port-wine stains (on and off the face), telangiectasia and pigmented scars using the optimum parameters for each lesion type as developed by the author, including the desired treatment endpoints.<br/>Results<br/>Good to excellent clearance in all lesion types was achieved in 1 to 6 sessions, 2-6 weeks apart. Some transient purpura, edema and erythema were seen, but no unexpected adverse events were reported, and patient satisfaction was universally very high with improved facial skin tone also being an additional benefit.<br/>Conclusions<br/>The new LP-KTP 532 system offered a safe and effective approach for clearance of a variety of vascular lesions with vessels at different depths. As parameters are fine-tuned and further developed, even greater efficacy can be expected with long-lasting results. |
15:40 - 15:55 | Yaei Togawa | Dermoscopy for red lesions In daily clinical practice, dermoscopy is often used primarily for the diagnosis of pigmented skin malignancies such as melanoma. However, this presentation will focus on the dermoscopic evaluation of red lesions. When a lesion appears red on human skin, this is primarily due to hemoglobin within red blood cells. The hemorrhage and capillary dilation in the upper dermis appear bright red, but as the depth increases, the color shifts to a red blue to purplish-red. This phenomenon is believed to occur because the red color of hemoglobin decreases in saturation as it becomes more distant from the skin surface.<br/>The following topics of red lesion will be discussed using cases experienced at our institution:<br/>1. Strawberry pattern and inverse strawberry pattern in actinic keratosis and discoid lupus erythematosus<br/>2. Dermoscopic findings of vascular tumors and vascular malformations based on ISSVA classification<br/>3. Dermoscopic findings in pyogenic granuloma and amelanotic melanocytic lesions <br/>4. Characteristic glomerular vessels in Bowen's disease and the impact of topical steroids<br/><br/>(Key words, dermocopy, vascular findings, amelanotic melanoma) |
Leong Kin Fon
General Hospital Kuala Lumpur Malaysia
Curriculum Vitae
Dr Leong Kin Fon is a consultant paediatric dermatologist from Women and Children hospital Kuala Lumpur. Dr Leong has been active in medical research, and has presented in numerous local and international conferences. Dr Leong has also authored and co-authored numerous scientific publications ( 143 publications according to researchgate ) and books; among which include The Faces of Atopic Eczema among Malaysian Children and the Atlas of Paediatric Diseases series. Dr Leong is the founder and president of malaysia eczema society since 2020 and the past president of the Malaysian Dystrophic Epidermolysis Bullosa Research Association (DEBRA Malaysia) from 2013 – 2022 He actively volunteers with various national & international humanitarian organizations such as MERCY, TIMA and Medecen San Frontier. Dr Leong has special interest in eczema, acne, psoriasis, birthmarks, portwine stain, nevus of Ota hemangioma, vascular lesions and common skin problems in children, adolescent and young adults. He was given ILDS humanitarian award in 2017 .
Kuo-Liang Cheng
Haute Beaute Skin Clinic Taiwan
Curriculum Vitae
Dr. Carl K. L. Cheng is a board certified dermatologist in Taiwan and interested in energy based devices such as laser, RF and ultrasound technology and various injectables and even cosmetic surgery. He also gave lectures in international congress such as ASLMS, IMCAS, AMWC, DASIL, ISD , WCD , Koreaderma and had trained many physicians in energy based devices and injectables in Asia. He was also a speaker, advisory board and medical consultant for many companies such as Cynosure, Candela, DEKA, Merz, Lumenis, Solta, Lutronic, BTL, Allergan, Galderma , etc.
Firas Al-Niaimi
Sk:n clinics London United Kingdom
Curriculum Vitae
Prof. Firas Al-Niaimi (MSc, MRCP, EBDV) is an award-winning Dermatologist with over 220 scientific publications in medical journals, 10 book chapters (and his own book) and over 400 scientific presentations in more than 83 countries around the globe. Professor Firas is one of the UK's most prolific and well-published dermatologists and one with a renowned international standing. He is a highly experienced and respected Consultant Dermatologist with nearly 20 years of medical experience and trained in some of the UK's top hospitals including the largest Dermatology Department in Europe (Manchester) and the world-renowned St. John's Institute of Dermatology at St. Thomas’ hospital where he completed a prestigious Laser and Mohs Surgical Fellowship there and continued to work as an Honorary Consultant for several years. Currently in addition to his private practice he is involved in academic research and international teaching and training of doctors and was awarded the "Global Excellence Award" for the title consultant dermatologist of the year 2019 in London given his services and commitment to dermatology. In 2021 he was appointed Professor in Dermatology and becomes the first and only professor in the Laser Dermatology in the UK.
Ivan Perez
University Hospital Fundación Santa Fe de Bogotá Colombia
Curriculum Vitae
CV Iván Pérez Haded Head and Chair of the Department of Dermatology, University Hospital Fundación Santafe de Bogotá Clinical Professor in Los Andes University - Bogotá. Member of the Colombian Society of Dermatology Vice president of the Colombian Society of Dermatológic Sugery Member of the American Academy of Dermatology Member of the European Academy of Dermatology and Venereology Member of the advisory board of Alopecia Areata for Pfizer Medical board Member ACD La Roche Posay Colombia.- KOL Speaker for Candela -Syneron KOL Speaker for Lutronic KOL - Speaker for Inmode Speaker Solta Medical Speaker Continuum Biomedical
Yaei Togawa
Department of Dermatology, Chiba University Hospital Japan
Curriculum Vitae
Yaei Togawa, MD, PhD EDUCATION 1993—1999 Tokyo Jikei University School of Medicine PROFESSIONAL EXPERIENCE AND POSITION 1999—2001 Resident in general Medicine, Asahi General Hospital, Chiba, Japan 2001—2003 Resident in Dermatology, Chiba University Hospital, Japan 2003—2007 Research Associate of Dermatology Department, Chiba University School of Medicine 2007—2021 Assistant Professor of Dermatology Department, Chiba University School of Medicine 2021— Lecturer of Dermatology Department, Chiba University Hospital (Observer visit to the Medical University of Vienna in October 2020) PUBLICATIONS (3 years) 1. Miyachi H, Sato D, Sakamaki K, Togawa Y, Yoshimura K. Impact of new antifungal medications on onychomycosis prescriptions and costs in Japan: A nationwide claims database study. J Dermatol. 2024;51:1172-1179. doi: 10.1111/1346-8138.17393 2. Kameda E, Matsuzawa T, Togawa Y, Hashimoto R, Saito T, Suzuki T, Inozume T. Amelanotic melanoma in oculocutaneous albinism type 4 detected using violet-light dermoscopy. J Dermatol. 2024;51:e261-e263. doi: 10.1111/1346-8138.17164.